Penumbra Inc (NYSE:PEN)
$ 186.94 -13.07 (-6.53%) Market Cap: 7.26 Bil Enterprise Value: 7.66 Bil PE Ratio: 549.82 PB Ratio: 6.25 GF Score: 82/100

Penumbra Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 12, 2021 / 03:50PM GMT
Release Date Price: $213.59 (+3.57%)
Robert Justin Marcus
JPMorgan Chase & Co, Research Division - Analyst

Welcome, everyone. Happy to continue the day here at the JPMorgan Healthcare Conference. I have the pleasure of introducing Adam Elsesser, the CEO of Penumbra. Before we get to it, Adam, though, I just want to let everyone know, you can go ahead and grab the slides at the website for the conference. (Operator Instructions)

So with that, Adam, take it away.

Adam Elsesser
Penumbra, Inc. - Co-Founder, Chairman, President & CEO

Well Thank you, Robbie, for the introduction. And of course, I want to thank JPMorgan for including us in this year's meeting.

Our -- Slide 2 has our safe harbor disclosure. And I'm going to just sort of call out the slides because I'm not able to control them here.

On Slide 3, we want to talk a little, maybe, about our mission as a company. Since our founding 16 years ago, Penumbra's mission has been simple. We focus on critical medical conditions and work tirelessly to innovate in these areas for years and years to perfect

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot